Foundayo (Orforglipron) for Weight Loss

Get Foundayo (orforglipron) prescribed online from ChatWithDr. Foundayo is a once-daily GLP-1 pill from Eli Lilly, FDA-approved in April 2026 for adults with obesity or overweight with a weight-related condition. As a small-molecule GLP-1 it can be taken any time of day with or without food or water. In the ATTAIN-1 trial (N Engl J Med. 2025;393:1796-1806, doi.org/10.1056/NEJMoa2511774), average weight loss at 72 weeks on the highest dose was 11.2% versus 2.1% with placebo; Eli Lilly reports 12.4% (about 27.3 lb) among participants who stayed on treatment. Dosing starts at 0.8 mg and steps up at intervals of at least 30 days through 2.5 mg and 5.5 mg toward 9 mg, 14.5 mg, or 17.2 mg. $39.99 consultation with board-certified doctors.